|
1
|
Anderson SD: Repurposing drugs as inhaled
therapies in asthma. Adv Drug Deliv Rev. 133:19–33. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tashkin DP, Lipworth B and Brattsand R:
Benefit: Risk profile of budesonide in obstructive airways disease.
Drugs. 79:1757–1775. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Fellström BC, Barratt J, Cook H, Coppo R,
Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli
F, et al: Targeted-release budesonide versus placebo in patients
with IgA nephropathy (NEFIGAN): A double-blind, randomised,
placebo-controlled phase 2b trial. Lancet. 389:2117–2127.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Floege J, Rauen T and Tang SCW: Current
treatment of IgA nephropathy. Semin Immunopathol. 43:717–728.
2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chang M, Yang B, Li L, Si Y, Zhao M, Hao
W, Zhao J and Zhang Y: Modified huangqi chifeng decoction
attenuates proteinuria by reducing podocyte injury in a rat model
of immunoglobulin a nephropathy. Front Pharmacol.
12(714584)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ismail G, Obrişcă B, Jurubiţă R, Andronesi
A, Sorohan B, Vornicu A, Sinescu I and Hârza M: Budesonide versus
systemic corticosteroids in IgA Nephropathy: A retrospective,
propensity-matched comparison. Medicine (Baltimore).
99(e21000)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang S, Dong L, Pei G, Jiang Z, Qin A, Tan
J, Tang Y and Qin W: High neutrophil-to-lymphocyte ratio is an
independent risk factor for end stage renal diseases in IgA
nephropathy. Front Immunol. 12(700224)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wakashin H, Heymann J, Roshanravan H,
Daneshpajouhnejad P, Rosenberg A, Shin MK, Hoek M and Kopp JB:
APOL1 renal risk variants exacerbate podocyte injury by increasing
inflammatory stress. BMC Nephrol. 21(371)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Leigh R, Mostafa MM, King EM, Rider CF,
Shah S, Dumonceaux C, Traves SL, McWhae A, Kolisnik T, Kooi C, et
al: An inhaled dose of budesonide induces genes involved in
transcription and signaling in the human airways: Enhancement of
anti- and proinflammatory effector genes. Pharmacol Res Perspect.
4(e00243)2016.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Li Y, Zheng D, Shen D, Zhang X, Zhao X and
Liao H: Protective effects of two safflower derived compounds,
kaempferol and hydroxysafflor yellow A, on hyperglycaemic
stress-induced podocyte apoptosis via modulating of macrophage
M1/M2 polarization. Immunol Res. 2020(2462039)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Al-Natour B, Rankin R, McKenna R, McMillan
H, Zhang SD, About I, Khan AA, Galicia JC, Lundy FT and El-Karim
IA: Identification and validation of novel biomarkers and
therapeutics for pulpitis using connectivity mapping. Int Endod J.
54:1571–1580. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sherman BT, Hao M, Qiu J, Jiao X, Baseler
MW, Lane HC, Imamichi T and Chang W: DAVID: A web server for
functional enrichment analysis and functional annotation of gene
lists (2021 update). Nucleic Acids Res. 50:W216–W221.
2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
The Gene Ontology Consortium. The gene
ontology resource: 20 years and still GOing strong. Nucleic Acids
Res. 47(D1):D330–D338. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Deng X, Gao J and Zhao F: Identification
of differentially expressed genes and pathways in kidney of
ANCA-associated vasculitis by integrated bioinformatics analysis.
Ren Fail. 44:204–216. 2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kanehisa M, Sato Y, Furumichi M, Morishima
K and Tanabe M: New approach for understanding genome variations in
KEGG. Nucleic Acids Res. 47:D590–D595. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Trybus E, Krol G, Obarzanowski T, Trybus
W, Kopacz-Bednarska A, Obarzanowski M and Krol T: In vivo and in
vitro studies on multidirectional mechanism of anti-allergic
activity of budesonide. J Physiol Pharmacol. 68:907–919.
2017.PubMed/NCBI
|
|
17
|
Kim HY, Cheon JH, Lee SH, Min JY, Back SY,
Song JG, Kim DH, Lim SJ and Han HK: Ternary nanocomposite carriers
based on organic clay-lipid vesicles as an effective colon-targeted
drug delivery system: Preparation and in vitro/in vivo
characterization. J Nanobiotechnology. 18(17)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xu G, Mo L, Wu C, Shen X, Dong H, Yu L,
Pan P and Pan K: The miR-15a-5p-XIST-CUL3 regulatory axis is
important for sepsis-induced acute kidney injury. Ren Fail.
41:955–966. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Peng Y, Liu L, Wang Y, Yao J, Jin F, Tao
T, Yuan H, Shi L and Lu S: Treatment with toll-like receptor 2
inhibitor ortho-vanillin alleviates lipopolysaccharide-induced
acute kidney injury in mice. Exp Ther Med. 18:4829–4837.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhang W, Qi R, Li T, Zhang X, Shi Y, Xu M
and Zhu T: Kidney organoids as a novel platform to evaluate
lipopolysaccharide-induced oxidative stress and apoptosis in acute
kidney injury. Front Med (Lausanne). 8(766073)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ying ZH, Li HM, Yu WY and Yu CH: Iridin
prevented against lipopolysaccharide-induced inflammatory responses
of macrophages via inactivation of PKM2-mediated glycolytic
pathways. J Inflamm Res. 14:341–354. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tong C, Wu H, Gu D, Li Y, Fan Y, Zeng J
and Ding W: Effect of curcumin on the non-alcoholic steatohepatitis
via inhibiting the M1 polarization of macrophages. Hum Exp Toxicol.
40 (12_suppl):S310–S317. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang C, Yue Y, Huang S, Wang K, Yang X,
Chen J, Huang J and Wu Z: M2b macrophages stimulate
lymphangiogenesis to reduce myocardial fibrosis after myocardial
ischaemia/reperfusion injury. Pharm Biol. 60:384–393.
2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang HX, Yuan J, Li YF and Li RS:
Thalidomide decreases high glucose-induced extracellular matrix
protein synthesis in mesangial cells via the AMPK pathway. Exp Ther
Med. 17:927–934. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ponticelli C and Locatelli F:
Glucocorticoids in the treatment of glomerular diseases: Pitfalls
and pearls. Clin J Am Soc Nephrol. 13:815–822. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Nuñez FJ, Johnstone TB, Corpuz ML,
Kazarian AG, Mohajer NN, Tliba O, Panettieri RA Jr, Koziol-White C,
Roosan MR and Ostrom RS: Glucocorticoids rapidly activate cAMP
production via Gαs to initiate non-genomic
signaling that contributes to one-third of their canonical genomic
effects. FASEB J. 34:2882–2895. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kan M, Koziol-White C, Shumyatcher M,
Johnson M, Jester W, Panettieri RA Jr and Himes BE: Airway smooth
muscle-specific transcriptomic signatures of glucocorticoid
exposure. Am J Respir Cell Mol Biol. 61:110–120. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhang H, Liu B, Jiang S, Wu JF, Qi CH,
Mohammadtursun N, Li Q, Li L, Zhang H, Sun J and Dong JC: Baicalin
ameliorates cigarette smoke-induced airway inflammation in rats by
modulating HDAC2/NF-κB/PAI-1 signalling. Pulm Pharmacol Ther.
70(102061)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Mostafa MM, Rider CF, Shah S, Traves SL,
Gordon PMK, Miller-Larsson A, Leigh R and Newton R:
Glucocorticoid-driven transcriptomes in human airway epithelial
cells: Commonalities, differences and functional insight from cell
lines and primary cells. BMC Med Genomics. 12(29)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang Y and Wang H: Efficacy of
montelukast sodium chewable tablets combined with inhaled
budesonide in treating pediatric asthma and its effect on
inflammatory factors. Pharmazie. 74:694–697. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chen L, Huang M and Xie N: The effect of
montelukast sodium plus budesonide on the clinical efficacy,
inflammation, and pulmonary function in children with cough variant
asthma. Am J Transl Res. 13:6807–6816. 2021.PubMed/NCBI
|
|
32
|
Zhang Y and Li B: Effects of montelukast
sodium plus budesonide on lung function, inflammatory factors, and
immune levels in elderly patients with asthma. Ir J Med Sci.
189:985–990. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Dong L, Zhu YH, Liu DX, Li J, Zhao PC,
Zhong YP, Chen YQ, Xu W and Zhu ZQ: Intranasal application of
budesonide attenuates lipopolysaccharide-induced acute lung injury
by suppressing nucleotide-binding oligomerization domain-like
receptor family, pyrin domain-containing 3 inflammasome activation
in mice. J Immunol Res. 2019(7264383)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Shapouri-Moghaddam A, Mohammadian S,
Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi
A, Afshari JT and Sahebkar A: Macrophage plasticity, polarization,
and function in health and disease. J Cell Physiol. 233:6425–6440.
2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lu J, Xie L and Sun S: The inhibitor
miR-21 regulates macrophage polarization in an experimental model
of chronic obstructive pulmonary disease. Tob Induc Dis.
19(69)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Chen Z, Wu H, Shi R, Fan W, Zhang J, Su W,
Wang Y and Li P: miRNAomics analysis reveals the promoting effects
of cigarette smoke extract-treated Beas-2B-derived exosomes on
macrophage polarization. Biochem Biophys Res Commun. 572:157–163.
2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Su JC, Zhang Y, Chen C, Zhu YN, Ye YM, Sun
YK, Xiang SY, Wang Y, Liu ZB and Zhang XF: Hydrogen regulates the
M1/M2 polarization of alveolar macrophages in a rat model of
chronic obstructive pulmonary disease. Exp Lung Res. 47:301–310.
2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lin YC, Lin YC, Tsai ML, Tsai YG, Kuo CH
and Hung CH: IL-33 regulates M1/M2 chemokine expression via
mitochondrial redox-related mitophagy in human monocytes. Chem Biol
Interact. 359(109915)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Li Q, Lu L, Li X and Lu S: Long non-coding
RNA NKILA alleviates airway inflammation in asthmatic mice by
promoting M2 macrophage polarization and inhibiting the NF-κB
pathway. Biochem Biophys Res Commun. 571:46–52. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Liu Y, Gao X, Miao Y, Wang Y, Wang H,
Cheng Z, Wang X, Jing X, Jia L, Dai L, et al: NLRP3 regulates
macrophage M2 polarization through up-regulation of IL-4 in asthma.
Biochem J. 475:1995–2008. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Shang Y, Sun Y, Xu J, Ge X, Hu Z, Xiao J,
Ning Y, Dong Y and Bai C: Exosomes from mmu_circ_0001359-modified
ADSCs attenuate airway remodeling by enhancing FoxO1
signaling-mediated M2-like macrophage activation. Mol Ther Nucleic
Acids. 19:951–960. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Han J, Pang X, Zhang Y, Peng Z, Shi X and
Xing Y: Hirudin protects against kidney damage in
streptozotocin-induced diabetic nephropathy rats by inhibiting
inflammation via P38 MAPK/NF-κB pathway. Drug Des Devel Ther.
14:3223–3234. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Fan HY, Wang XK, Li X, Ji K, Du SH, Liu Y,
Kong LL, Xu JC, Yang GQ, Chen DQ and Qi D: Curcumin, as a
pleiotropic agent, improves doxorubicin-induced nephrotic syndrome
in rats. J Ethnopharmacol. 250(112502)2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Yu N, Yang L, Ling L, Liu Y, Yu Y, Wu Q,
Gu Y and Niu J: Curcumin attenuates angiotensin II-induced podocyte
injury and apoptosis by inhibiting endoplasmic reticulum stress.
FEBS Open Bio. 10:1957–1966. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Zhang P, Fang J, Zhang J, Ding S and Gan
D: Curcumin inhibited podocyte cell apoptosis and accelerated cell
autophagy in diabetic nephropathy via regulating
Beclin1/UVRAG/Bcl2. Diabetes Metab Syndr Obes. 13:641–652.
2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Shi L, Xiao C, Zhang Y, Xia Y, Zha H, Zhu
J and Song Z: Vitamin D/vitamin D receptor/Atg16L1 axis maintains
podocyte autophagy and survival in diabetic kidney disease. Ren
Fail. 44:694–705. 2022.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Li M, Liu X and Zhang Z: Hyperglycemia
exacerbates cadmium-induced glomerular nephrosis. Toxicol Ind
Health. 37:555–563. 2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Wadey KS, Somos A, Cross SJ, Reolizo LM,
Johnson JL and George SJ: Monitoring cellular proliferation,
migration, and apoptosis associated with atherosclerosis plaques in
vitro. Methods Mol Biol. 2419:133–167. 2022.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Liu QZ, Chen XD, Liu G and Guan GJ:
Identification and isolation of kidney-derived stem cells from
transgenic rats with diphtheria toxin-induced kidney damage. Exp
Ther Med. 12:1651–1656. 2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Suzuki T, Eng DG, McClelland AD, Pippin JW
and Shankland SJ: Cells of NG2 lineage increase in glomeruli of
mice following podocyte depletion. Am J Physiol Renal Physiol.
315:F1449–F1464. 2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Wei SY, Guo S, Feng B, Ning SW and Du XY:
Identification of miRNA-mRNA network and immune-related gene
signatures in IgA nephropathy by integrated bioinformatics
analysis. BMC Nephrol. 22(392)2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Peng W, Pei GQ, Tang Y, Tan L and Qin W:
IgA1 deposition may induce NLRP3 expression and macrophage
transdifferentiation of podocyte in IgA nephropathy. J Transl Med.
17(406)2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Ji L, Chen Y, Wang H, Zhang W, He L, Wu J
and Liu Y: Overexpression of Sirt6 promotes M2 macrophage
transformation, alleviating renal injury in diabetic nephropathy.
Int J Oncol. 55:103–115. 2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Yang H, Xie T, Li D, Du X, Wang T, Li C,
Song X, Xu L, Yi F, Liang X, et al: Tim-3 aggravates podocyte
injury in diabetic nephropathy by promoting macrophage activation
via the NF-κB/TNF-α pathway. Mol Metab. 23:24–36. 2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Liao H, Li Y, Zhang X, Zhao X, Zheng D,
Shen D and Li R: Protective effects of thalidomide on
high-glucose-induced podocyte injury through in vitro modulation of
macrophage M1/M2 differentiation. J Immunol Res.
2020(8263598)2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Kong DH, Kim YK, Kim MR, Jang JH and Lee
S: Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in
immunological disorders and cancer. Int J Mol Sci.
19(1057)2018.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Wagner C, Uliczka K, Bossen J, Niu X, Fink
C, Thiedmann M, Knop M, Vock C, Abdelsadik A, Zissler UM, et al:
Constitutive immune activity promotes JNK- and FoxO-dependent
remodeling of Drosophila airways. Cell Rep.
35(108956)2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Caramori G, Ruggeri P, Arpinelli F, Salvi
L and Girbino G: Long-term use of inhaled glucocorticoids in
patients with stable chronic obstructive pulmonary disease and risk
of bone fractures: A narrative review of the literature. Int J
Chron Obstruct Pulmon Dis. 14:1085–1097. 2019.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Almeida M and Porter RM: Sirtuins and
FoxOs in osteoporosis and osteoarthritis. Bone. 121:284–292.
2019.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Long Z, Wu J, Xiang W, Zeng Z, Yu G and Li
J: Exploring the mechanism of icariin in osteoporosis based on a
network pharmacology strategy. Med Sci Monit.
26(e924699)2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Pattrapornpisut P, Avila-Casado C and
Reich HN: IgA nephropathy: Core curriculum 2021. Am J Kidney Dis.
78:429–441. 2021.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Barbour SJ, Coppo R, Zhang H, Liu ZH,
Suzuki Y, Matsuzaki K, Katafuchi R, Er L, Espino-Hernandez G, Kim
SJ, et al: Evaluating a new international risk-prediction tool in
IgA nephropathy. JAMA Intern Med. 179:942–952. 2019.PubMed/NCBI View Article : Google Scholar
|
